February 2022 FDA Recall Drug by Preferred Pharmaceuticals, Inc.
D-0642-2022 - CGMP deviations

This Class II drug recall was voluntarily initiated by Preferred Pharmaceuticals, Inc. on February 22, 2022 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0642-2022

Reason for Recall
CGMP deviations
Initiated
02-22-2022
Reported
03-09-2022
Quantity
276 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Preferred Pharmaceuticals, Inc.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Nationwide in the USA.
Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets per bottle, NDC: 68788-6381-06, c) 90 tablets per bottle, NDC: 68788-6381-09, Mfg: Par Pharmaceutical.

Batch or Lot Expiration Information

Lot# s: a) G2919M, I0619O, F1419J; b) H3019Q; c) F1219N, F1919D, H0219D, I0519R, J0319G, Exp. 03/31/2022.